Benefits of FK506 (tacrolimus) for residual, cyclosporine-and prednisone-resistant myasthenia gravis : one-year follow up of an open-label study
収録刊行物
-
- Clin Neurol Neurosurg
-
Clin Neurol Neurosurg 107 187-190, 2005